Работы, на которые ссылается эта работа

Работ: 97

Работа: Emerging roles of long noncoding RNA H19 in human lung cancer

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

   Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4

   СтатьяGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians2021Цитирований: 60

   ABIABI:AkademIndex/openalex/2026.other.000045

2. Non-coding RNA in cancer

   Huiwen Yan, Pengcheng Bu

   Обзорная статья2021Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.418816

3. Hypoxia-inducible factors: cancer progression and clinical translation

   Elizabeth E. Wicks, Gregg L. Semenza

   Обзорная статья2022Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.121431

4. Role of noncoding RNAs and untranslated regions in cancer: A review

   Yiping Zhang, Mei-wen Yang, Shu‐Long Yang +1

   Обзорная статья2022Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.282891

5. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies

   Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou +3

   Обзорная статья2023Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.289211

6. Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches

   Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou +4

   Обзорная статья2023Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.289212

7. H19 lncRNA: Roles in tumorigenesis

   Soudeh Ghafouri‐Fard, Mohammadhosein Esmaeili, Mohammad Taheri

   Обзорная статья2019Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.303360

8. The double-edged sword of H19 lncRNA: Insights into cancer therapy

   Yun Wei Shermane Lim, Xiaoqiang Xiang, Manoj Garg +4

   Обзорная статья2020Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.003202

9. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

   Qiang Tang, Jinhuang Chen, Ziyang Di +8

   Статья2020Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.149076

10. EMT, cancer stem cells and autophagy; The three main axes of metastasis

    Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Nasrin Zare Zavieyh Jaghi

    Обзорная статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.149080

11. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy

    Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed +10

    Обзорная статья2022Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.224139

12. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

    Hao Yang, D.A. Baker, Peter ten Dijke

    Обзорная статья2019Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.322687

13. The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory

    Eli Raveh, Imad Matouk, Michal Gilon +1

    Обзорная статья2015Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.332280

14. Hypoxia upregulates the expression of lncRNA H19 in non-small cell lung cancer cells and induces drug resistance

    Haiyan Li, Jinwei Wang, Yingying Jin +3

    Статья2022Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.332478

15. Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells

    Feng Yang, Jianwei Bi, Xuchao Xue +4

    Статья2012Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418764

16. p53 polymorphisms: cancer implications

    Catherine Whibley, Paul D.P. Pharoah, Monica Hollstein

    Обзорная статья2009Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418770

17. The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision

    Imad Matouk, David Halle, Eli Raveh +3

    Обзорная статья2015Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418774

18. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer

    Yi Lei, Guo Wang, Bowang Chen +3

    Статья2018Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418787

19. EMT Transition States during Tumor Progression and Metastasis

    Ievgenia Pastushenko, Cédric Blanpain

    Обзорная статья2018Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418791

20. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function

    Yi Zhao, Changjiang Feng, Yunjing Li +2

    Статья2019Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418796

21. <p>Exosomal Transfer of lncRNA H19 Promotes Erlotinib Resistance in Non-Small Cell Lung Cancer via miR-615-3p/ATG7 Axis</p>

    Rongtao Pan, Haiyan Zhou

    Статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418811

22. Decoding hepatocarcinogenesis from a noncoding RNAs perspective

    Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos +3

    Обзорная статья2023Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418838

23. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer

    Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy

    Обзорная статья2023Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.418839

24. Без названия

    ДругоеЦитирований: 1

    ABIABI:AkademIndex/openalex/2026.other.418765

25. Без названия

    ДругоеЦитирований: 1

    ABIABI:AkademIndex/openalex/2026.other.418766